Drug Trial Radar · NCT06999733
A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis
Last checked: Nov 19, 2026Latest source record: Feb 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Jul 7, 2025
Primary completion
Dec 2026
Study completion Dec 2027
Sponsor
- Lead sponsor
- Krystal Biotech, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 31, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Sponsor is developing KB801, a replication-defective, non-integrating herpes simplex virus type 1 (HSV-1)-derived vector engineered to deliver functional full-length human nerve growth factor (NGF) to the corneas of people with Stage 2 or 3 neurotrophic keratitis (NK) via topical application. This is a Phase 1/2, multicenter, double-masked, placebo-controlled study to evaluate the safety, tolerability, and preliminary efficacy of KB801 in these subjects.
Conditions
- Neurotrophic Keratitis
Interventions
KB801Biological
Ophthalmic suspension of replication-defective, non-integrating herpes simplex virus type 1 (HSV-1)-based vector delivering functional, full-length human nerve growth factor (NGF)
PlaceboDrug
Vehicle
Primary outcomes
What the sponsor says the trial is designed to measure.
- To evaluate safety and tolerability of KB801 based upon assessment of adverse events (frequency, severity, relatedness).Time frame: 8 weeks
- To evaluate the effect of KB801 on complete healing of the Persistent Corneal Epithelial Defect (PCED) in subjects with Stage 2 or Stage 3 NKTime frame: 8 weeks
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
UC Irvine Alpha Clinic
Irvine, California · Not yet recruiting
Azul Vision - California Eye Specialists Medical Group Inc.
Pasadena, California · Recruiting
Midwest Cornea Associates
Carmel, Indiana · Recruiting
Vance Thompson Vision
Alexandria, Minnesota · Recruiting
Minnesota Eye Consultants
Minnetonka, Minnesota · Recruiting
St. Louis Eye Institute
Town and Country, Missouri · Recruiting
Metropolitan Eye Research and Surgery Institute
Palisades Park, New Jersey · Recruiting
Vance Thompson Vision
West Fargo, North Dakota · Recruiting
UPMC Vision Institute
Pittsburgh, Pennsylvania · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.